Receptor Life Sciences, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Receptor Life Sciences, Inc. - overview
Established
2015
Location
Seattle, WA, US
Primary Industry
Pharmaceuticals
About
Based in Washington, US, and founded by Gregory F. Wesner and Andrea Leone-Bay in 2015, Receptor Life Sciences, Inc is a pharmaceutical company that applies FDA-approved drug delivery technologies to develop innovative therapies to address central nervous system disorders. The companies use these technologies to produce inhaled and oral cannabinoid products that hold the potential to provide precision, consistency, reliability, and convenience.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceuticals
Website
www.receptorlife.com
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.